54 Relationship between rate of percent predicted FEV1 (ppFEV1) decline and baseline and acute change in ppFEV1 in patients (pts) with cystic fibrosis (CF) treated with lumacaftor/ivacaftor (LUM/IVA)

Autor: Konstan, M.W., McKone, E.F., Moss, R.B., Lubarsky, B., Rubin, J., Millar, S.J., Pasta, D.J., Mayer-Hamblett, N., Goss, C.H., Morgan, W., Sawicki, G.S.
Zdroj: In Journal of Cystic Fibrosis June 2017 16 Supplement 1:S78-S78
Databáze: ScienceDirect